EMPATIA@Lecco- Balance Rehabilitation of Autistic Children With Virtual rEality (BRAVE)

September 28, 2023 updated by: IRCCS Eugenio Medea
The general objective of this project is to investigate the possible efficacy of a training based on proprioceptive and visual feedback carried out with the GRAIL (Motekforce Link) virtual reality environment on postural control and balance skills of school-aged children with clinical diagnosis of ASD.

Study Overview

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Lecco
      • Bosisio Parini, Lecco, Italy, 23842
        • Scientific Institute IRCCS E. Medea

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 14 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • a clinical diagnosis of ASD
  • All participants were required to have estimated FSIQ of 80 or above

Exclusion Criteria:

  • using any stimulant or non-stimulant medication that affects the central nervous system
  • having an identified genetic disorder
  • having vision or hearing problems
  • suffering from chronic or acute medical illness
  • presence of epilepsy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GRAIL
The participants will perform exergames on GRAIL immersive virtual reality to improve balance (e.g. load shifts, exercises with adaptations to motor perturbations). GRAIL can provide proprioceptive and visual feedback to participants.
No Intervention: No treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
experimental balance assessment
Time Frame: approximately 6 weeks after starting the intervention
Balance assessment through the evaluation (with both open and closed eyes) of the center of pression using the GRAIL platform
approximately 6 weeks after starting the intervention
Movement Assessment Battery for Children 2 (MABC2) (Henderson et al., 2007).
Time Frame: approximately 6 weeks after starting the intervention
The MABC2 consists of eight subtests that evaluate three components of motor proficiency: manual dexterity, ball skills, and static and dynamic balance. For the MABC2, higher scores are indicative of better motor performance.
approximately 6 weeks after starting the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Developmental Coordination Disorder Questionnaire (DCDQ) (Wilson et al., 2007).
Time Frame: approximately 6 weeks after starting the intervention
The DCDQ is a 15-item questionnaire that investigates gross and fine motor skill impairments. The DCDQ yields a raw total score (score range 15-75); higher scores indicate better motor functioning as rated by the parents.
approximately 6 weeks after starting the intervention
assessment of balance in response to perturbation applied by accelerating the dual-belt treadmill the dominant side at toe-off
Time Frame: approximately 6 weeks after starting the intervention
assessment of balance in response to perturbation applied by accelerating the dual-belt treadmill
approximately 6 weeks after starting the intervention
assessment of overground balance using GSENSOR (BTS Bioengineering), a medical device for motion analysis
Time Frame: approximately 6 weeks after starting the intervention
assessment of overground balance using GSENSOR (BTS Bioengineering), a medical device for motion analysis
approximately 6 weeks after starting the intervention
evaluation of gait features using the GRAIL (Motekforce Link)
Time Frame: approximately 6 weeks after starting the intervention
evaluation of gait features using the GRAIL (Motekforce Link)
approximately 6 weeks after starting the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 18, 2019

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

February 18, 2020

First Submitted That Met QC Criteria

February 18, 2020

First Posted (Actual)

February 19, 2020

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 28, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on exergames with GRAIL virtual immersive reality environment

3
Subscribe